The proceeds will also help launch HistoSonics' BOOMBOX study, to evaluate Edison’s use against liver cancer among multidisciplinary healthcare providers. A separate study is exploring its capability ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The FDA gave HistoSonics market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results